AdvaMed Praises CMS Draft Rule Improving Access to Alzheimer’s, Cancer Diagnostics
AdvaMed commended CMS for its July 10 proposed rule that includes separate payments for diagnostic radiopharmaceuticals are used to diagnose and treat diseases such as Alzheimer’s and cancer. Source: Drug…